|Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?|
T McLaughlin, G Reaven, F Abbasi, C Lamendola, M Saad, D Waters, ...
The American journal of cardiology 96 (3), 399-404, 2005
|Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-progestin Replacement Study (HERS)|
JA Simon, J Hsia, JA Cauley, C Richards, F Harris, J Fong, ...
Circulation 103 (5), 638-642, 2001
|Estrogen and progestin, lipoprotein (a), and the risk of recurrent coronary heart disease events after menopause|
MG Shlipak, JA Simon, E Vittinghoff, F Lin, E Barrett-Connor, RH Knopp, ...
Jama 283 (14), 1845-1852, 2000
|Serum fatty acids and the risk of coronary heart disease|
JA Simon, ML Hodgkins, WS Browner, JM Neuhaus, JT Bernert Jr, ...
American journal of epidemiology 142 (5), 469-476, 1995
|Vitamin C and cardiovascular disease: a review.|
Journal of the American College of Nutrition 11 (2), 107-125, 1992
|Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease|
MG Shlipak, JA Simon, D Grady, F Lin, NK Wenger, CD Furberg
Journal of the American College of Cardiology 38 (3), 705-711, 2001
|Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study|
JA Simon, F Lin, SB Hulley, PJ Blanche, D Waters, S Shiboski, JI Rotter, ...
The American journal of cardiology 97 (6), 843-850, 2006
|Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III)|
JA Simon, ES Hudes
Archives of internal medicine 160 (7), 931-936, 2000
|Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease|
DM Herrington, E Vittinghoff, TD Howard, DA Major, J Owen, ...
Arteriosclerosis, thrombosis, and vascular biology 22 (6), 1012-1017, 2002
RM Krauss, LM Mangravite, JD Smith, MW Medina, D Wang, X Guo, ...
Circulation 117 (12), 1537-1544, 2008
|Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women’s Health Initiative–|
RL Wolf, JA Cauley, M Pettinger, R Jackson, A Lacroix, MS Leboff, ...
The American journal of clinical nutrition 82 (3), 581-588, 2005
|Serum fatty acids and the risk of stroke|
JA Simon, J Fong, JT Bernert Jr, WS Browner
Stroke 26 (5), 778-782, 1995
|Relationship of ascorbic acid to blood lead levels|
JA Simon, ES Hudes
Jama 281 (24), 2289-2293, 1999
|Relation of smoking and alcohol consumption to serum fatty acids|
JA Simon, J Fong, JT Bemert Jr, WS Browner
American journal of epidemiology 144 (4), 325-334, 1996
|Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial|
JA Simon, TP Carmody, ES Hudes, E Snyder, J Murray
The American journal of medicine 114 (7), 555-562, 2003
|Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study|
J Hsia, JA Simon, F Lin, WB Applegate, MT Vogt, D Hunninghake, M Carr
Circulation 102 (18), 2228-2232, 2000
|Hypnosis for smoking cessation: a randomized trial|
TP Carmody, C Duncan, JA Simon, S Solkowitz, J Huggins, S Lee, ...
Nicotine & Tobacco Research 10 (5), 811-818, 2008
|The relation of α-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis|
JA Simon, YH Chen, S Bent
The American journal of clinical nutrition 89 (5), 1558S-1564S, 2009
|Smoking cessation after surgery: a randomized trial|
JA Simon, SN Solkowitz, TP Carmody, WS Browner
Archives of Internal Medicine 157 (12), 1371-1376, 1997
|Relation of serum ascorbic acid to mortality among US adults|
JA Simon, ES Hudes, JA Tice
Journal of the American College of Nutrition 20 (3), 255-263, 2001